A study examined the feasibility of using circulating free DNA (cfDNA) from blood samples of patients with advanced non-small-cell lung cancer as a surrogate for tumor biopsies to determine tumor-causing epidermal growth factor receptor (EGFR) mutations and then…
Source: Blood samples as surrogates for tumor biopsies in patients with lung cancer
Friday, February 27, 2015
Blood samples as surrogates for tumor biopsies in patients with lung cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment